Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Clinical trial NCT03126708 · UNKNOWN

Trial details

NCT number: NCT03126708
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer, Squamous Cell Cetuximab Effect Chemotherapy Effect

Start date: 2017-04-10
Primary completion: 2019-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.